Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2015 | 05-2014 | 05-2013 | 05-2012 | 05-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,701 | 4,737 | 7,594 | 4,720 | 8,475 |
| Marketable Securities | 2,455 | 1,702 | 195 | 2,907 | 2,207 |
| Receivables | N/A | N/A | 17 | N/A | 129 |
| Other current assets | 0 | 58 | 41 | 7 | 258 |
| TOTAL | $5,176 | $6,700 | $8,041 | $7,860 | $12,196 |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 5 | 8 | 10 |
| Investments And Advances | 0 | 96 | 366 | 229 | 300 |
| Other Non-Current Assets | 3 | 3 | 3 | 42 | 92 |
| TOTAL | $6 | $102 | $374 | $279 | $402 |
| Total Assets | $5,182 | $6,801 | $8,415 | $8,138 | $12,597 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39 | 224 | 219 | 240 | 306 |
| Accrued Expenses | 57 | 63 | 59 | 65 | 54 |
| TOTAL | $96 | $290 | $278 | $307 | $576 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 69 | 0 | 0 | 741 | 3 |
| TOTAL | $69 | $N/A | $N/A | $741 | $3 |
| Total Liabilities | $165 | $290 | $278 | $1,048 | $579 |
| Shareholders' Equity | |||||
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -57,806 | -56,268 | -54,801 | -55,898 | -51,077 |
| Other shareholders' equity | 374 | 374 | -404 | -347 | -223 |
| TOTAL | $5,016 | $6,511 | $8,137 | $7,091 | $12,019 |
| Total Liabilities And Equity | $5,182 | $6,801 | $8,415 | $8,138 | $12,597 |